Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$28.04 +0.66 (+2.39%)
As of: Nov 11, 2026 · 3:13 PM EST

Arcutis Biotherapeutics (ARQT) Price to FCF (2026)

Updated

Arcutis Biotherapeutics' Price to FCF came in at 84.11 for Q2 2026, down 23.2% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Price to FCF (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 55.78
Jun 30, 2026 84.11
Mar 31, 2026 109.45
API Access

Arcutis Biotherapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=ARQT&period=max&api_key=YOUR_API_KEY